Karl Melber

1.8k total citations
24 papers, 1.5k citations indexed

About

Karl Melber is a scholar working on Immunology, Molecular Biology and Epidemiology. According to data from OpenAlex, Karl Melber has authored 24 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Immunology, 11 papers in Molecular Biology and 10 papers in Epidemiology. Recurrent topics in Karl Melber's work include Immunotherapy and Immune Responses (12 papers), Hepatitis B Virus Studies (10 papers) and Immune Response and Inflammation (4 papers). Karl Melber is often cited by papers focused on Immunotherapy and Immune Responses (12 papers), Hepatitis B Virus Studies (10 papers) and Immune Response and Inflammation (4 papers). Karl Melber collaborates with scholars based in Germany, Switzerland and United States. Karl Melber's co-authors include Jörg Reimann, Reinhold Schirmbeck, Zbigniew A. Janowicz, Thomas Mertens, Gerd Gellissen, W Böhm, Cornelis P. Hollenberg, Andreas Kuhröber, R. Kath and Meenhard Herlyn and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Journal of Immunology and Journal of Virology.

In The Last Decade

Karl Melber

24 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Karl Melber Germany 21 750 654 543 201 129 24 1.5k
Lars Östberg Sweden 27 698 0.9× 843 1.3× 423 0.8× 189 0.9× 121 0.9× 47 1.9k
Toshitaka Akatsuka Japan 24 706 0.9× 439 0.7× 621 1.1× 576 2.9× 312 2.4× 55 1.8k
Michael P. Malakhov United States 10 921 1.2× 1.0k 1.6× 422 0.8× 76 0.4× 162 1.3× 15 1.9k
Lih‐Hwa Hwang Taiwan 26 322 0.4× 443 0.7× 484 0.9× 545 2.7× 187 1.4× 54 1.4k
Adrien Breiman France 23 367 0.5× 627 1.0× 387 0.7× 121 0.6× 578 4.5× 46 1.6k
Christopher J. McCormick United Kingdom 20 268 0.4× 281 0.4× 425 0.8× 527 2.6× 178 1.4× 41 1.3k
Penelope Mavromara Greece 23 219 0.3× 425 0.6× 613 1.1× 760 3.8× 125 1.0× 68 1.4k
Zhikang Qian China 24 280 0.4× 585 0.9× 597 1.1× 45 0.2× 137 1.1× 50 1.3k
Eric J. Patzer United States 19 615 0.8× 812 1.2× 433 0.8× 93 0.5× 454 3.5× 24 1.9k
Kyung-Won Huh United States 10 340 0.5× 857 1.3× 1.2k 2.2× 209 1.0× 70 0.5× 10 2.0k

Countries citing papers authored by Karl Melber

Since Specialization
Citations

This map shows the geographic impact of Karl Melber's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Karl Melber with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Karl Melber more than expected).

Fields of papers citing papers by Karl Melber

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Karl Melber. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Karl Melber. The network helps show where Karl Melber may publish in the future.

Co-authorship network of co-authors of Karl Melber

This figure shows the co-authorship network connecting the top 25 collaborators of Karl Melber. A scholar is included among the top collaborators of Karl Melber based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Karl Melber. Karl Melber is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Dembek, Claudia J., Clemens Jäger, Uta Drebber, et al.. (2013). A novel therapeutic hepatitis B vaccine induces cellular and humoral immune responses and breaks tolerance in hepatitis B virus (HBV) transgenic mice. Vaccine. 31(8). 1197–1203. 72 indexed citations
2.
Schirmbeck, Reinhold, Waltraud Böhm, Nicolás Fissolo, Karl Melber, & Jörg Reimann. (2003). Different immunogenicity of H‐2 Kb‐restricted epitopes in natural variants of the hepatitis B surface antigen. European Journal of Immunology. 33(9). 2429–2438. 28 indexed citations
3.
Schirmbeck, Reinhold, Nektarios Dikopoulos, Marcin Kwissa, et al.. (2003). Breaking tolerance in hepatitis B surface antigen (HBsAg) transgenic mice by vaccination with cross‐reactive, natural HBsAg variants. European Journal of Immunology. 33(12). 3342–3352. 36 indexed citations
4.
Riedl, Petra, et al.. (2002). Priming Th1 Immunity to Viral Core Particles Is Facilitated by Trace Amounts of RNA Bound to Its Arginine-Rich Domain. The Journal of Immunology. 168(10). 4951–4959. 87 indexed citations
5.
6.
7.
Thiel, Eckhard, et al.. (2001). Measurement of Hematological, Clinical Chemistry, and Infection Parameters from Hirudinized Blood Collected in Universal Blood Sampling Tubes. Seminars in Thrombosis and Hemostasis. 27(4). 349–356. 7 indexed citations
8.
Melber, Karl, et al.. (2001). The Use of Hirudin as Universal Anticoagulant in Haematology, Clinical Chemistry and Blood Grouping. Clinical Chemistry and Laboratory Medicine (CCLM). 39(12). 1267–77. 15 indexed citations
9.
Gellissen, Gerd & Karl Melber. (1996). Methylotrophic yeast hansenula polymorpha as production organism for recombinant pharmaceuticals.. PubMed. 46(9). 943–8. 33 indexed citations
10.
11.
Böhm, W, Reinhold Schirmbeck, A Elbe, et al.. (1995). Exogenous hepatitis B surface antigen particles processed by dendritic cells or macrophages prime murine MHC class I-restricted cytotoxic T lymphocytes in vivo. The Journal of Immunology. 155(7). 3313–3321. 88 indexed citations
12.
Schirmbeck, Reinhold, W Böhm, Karl Melber, & Jörg Reimann. (1995). Processing of exogenous heat-aggregated (denatured) and particulate (native) hepatitis B surface antigen for class I-restricted epitope presentation. The Journal of Immunology. 155(10). 4676–4684. 82 indexed citations
13.
Melber, Karl, et al.. (1994). Selective stimulation of murine cytotoxic T cell and antibody responses by particulate or monomeric hepatitis B virus surface (S) antigen. European Journal of Immunology. 24(5). 1088–1096. 51 indexed citations
14.
Schirmbeck, Reinhold, Karl Melber, Andreas Kuhröber, Zbigniew A. Janowicz, & Jörg Reimann. (1994). Immunization with soluble hepatitis B virus surface protein elicits murine H-2 class I-restricted CD8+ cytotoxic T lymphocyte responses in vivo.. The Journal of Immunology. 152(3). 1110–1119. 140 indexed citations
15.
Schirmbeck, Reinhold, Karl Melber, Thomas Mertens, & Jörg Reimann. (1994). Antibody and cytotoxic T-cell responses to soluble hepatitis B virus (HBV) S antigen in mice: implication for the pathogenesis of HBV-induced hepatitis. Journal of Virology. 68(3). 1418–1425. 86 indexed citations
16.
Gellissen, Gerd, Karl Melber, Zbigniew A. Janowicz, et al.. (1992). Heterologous protein production in yeast. Antonie van Leeuwenhoek. 62(1-2). 79–93. 60 indexed citations
17.
Gellissen, Gerd, Zbigniew A. Janowicz, Ulrike Weydemann, et al.. (1992). High-level expression of foreign genes in Hansenula polymorpha. Biotechnology Advances. 10(2). 179–189. 33 indexed citations
18.
Janowicz, Zbigniew A., Karl Melber, Armin Merckelbach, et al.. (1991). Simultaneous expression of the S and L surface antigens of hepatitis B, and formation of mixed particles in the methylotrophic yeast, Hansenula polymorpha. Yeast. 7(5). 431–443. 118 indexed citations
19.
Rodeck, Ulrich, Karl Melber, R. Kath, et al.. (1991). Constitutive Expression of Multiple Growth Factor Genes by Melanoma Cells but Not Normal Melanocytes. Journal of Investigative Dermatology. 97(1). 20–26. 146 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Lars Östberg Breakdown of academic impact, for papers by Toshitaka Akatsuka Breakdown of academic impact, for papers by Michael P. Malakhov Breakdown of academic impact, for papers by Lih‐Hwa Hwang Breakdown of academic impact, for papers by Adrien Breiman Breakdown of academic impact, for papers by Christopher J. McCormick Breakdown of academic impact, for papers by Penelope Mavromara Breakdown of academic impact, for papers by Zhikang Qian Breakdown of academic impact, for papers by Eric J. Patzer Breakdown of academic impact, for papers by Kyung-Won Huh
Rankless by CCL
2026